NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

This is about "re-review." They likely have what they need for OS, almost certainly, but they "desperately need" PFS surrogates, and to do that, they need to get PFS right in this trial. The end is the perfect time to do that -- as Doc pointed out the regs on that. It could help many trials in the future.

I applaud their efforts. I hope they are done with their re-review of PFS.

LL talks about it to a private audience, the Journal talks about it publicly, but NWBO says nothing. Why? It's not a state secret? The internal timeline should also not be a state secret.